Immunotherapy: balancing the risks and benefits

Lancet Oncol. 2024 Feb;25(2):147. doi: 10.1016/S1470-2045(24)00028-7.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Humans
  • Immunotherapy* / adverse effects
  • Risk Assessment